Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed Eslam

Showing results (41-50 of 224) with videos related to

Pageof 23
Sort By:
Current Opinion in Pharmacology|August 29, 2021
An update on drug development for the treatment of metabolic (dysfunction) associated fatty liver disease: Progress and opportunitiesZiyan Pan, Jian-Gao Fan, Mohammed Eslam
Gastroenterology|February 12, 2020
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver DiseaseMohammed Eslam, Arun J Sanyal, Jacob George, et al.
Hepatobiliary Surgery and Nutrition|January 10, 2022
The role of B cells in metabolic (dysfunction)-associated fatty liver diseaseZiyan Pan, Wah-Kheong Chan, Mohammed Eslam
Alimentary Pharmacology & Therapeutics|September 25, 2018
Editorial: STAT-4 polymorphism - a tool to personalise clinical practice in chronic HBV infection. Authors' replyRasha El Sharkawy, Jacob George, Mohammed Eslam
Hepatology International|April 17, 2023
MAFLD and chronic kidney disease: two sides of the same coin?Ziyan Pan, Saleh A Alqahtani, Mohammed Eslam
Liver International : Official Journal of the International Association for the Study of the Liver|May 4, 2026
Assessment of MAFLD/MASLD Classification Using the Updated Lancet Obesity DefinitionAlaa M Mostafa, Yasser Fouad, Mohammed Eslam
Gut|January 22, 2011
Insulin resistance and hepatitis C: an evolving storyMohammed Eslam, Mahmoud Aboelneen Khattab, Stephen A Harrison
World Journal of Gastroenterology|May 12, 2020
Macrophages in metabolic associated fatty liver diseaseJawaher Alharthi, Olivier Latchoumanin, Jacob George, et al.
Trends in Genetics : TIG|May 13, 2020
The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver DiseaseAli Bayoumi, Henning Grønbæk, Jacob George, et al.
Hormones (Athens, Greece)|August 3, 2022
Detangling the interrelations between MAFLD, insulin resistance, and key hormonesShreya C Pal, Mohammed Eslam, Nahum Mendez-Sanchez
Pageof 23

Showing results (41-50 of 224) with videos related to

Sort By:
Pageof 23
Current Opinion in Pharmacology|August 29, 2021
An update on drug development for the treatment of metabolic (dysfunction) associated fatty liver disease: Progress and opportunitiesZiyan Pan, Jian-Gao Fan, Mohammed Eslam
Gastroenterology|February 12, 2020
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver DiseaseMohammed Eslam, Arun J Sanyal, Jacob George, et al.
Hepatobiliary Surgery and Nutrition|January 10, 2022
The role of B cells in metabolic (dysfunction)-associated fatty liver diseaseZiyan Pan, Wah-Kheong Chan, Mohammed Eslam
Alimentary Pharmacology & Therapeutics|September 25, 2018
Editorial: STAT-4 polymorphism - a tool to personalise clinical practice in chronic HBV infection. Authors' replyRasha El Sharkawy, Jacob George, Mohammed Eslam
Hepatology International|April 17, 2023
MAFLD and chronic kidney disease: two sides of the same coin?Ziyan Pan, Saleh A Alqahtani, Mohammed Eslam
Liver International : Official Journal of the International Association for the Study of the Liver|May 4, 2026
Assessment of MAFLD/MASLD Classification Using the Updated Lancet Obesity DefinitionAlaa M Mostafa, Yasser Fouad, Mohammed Eslam
Gut|January 22, 2011
Insulin resistance and hepatitis C: an evolving storyMohammed Eslam, Mahmoud Aboelneen Khattab, Stephen A Harrison
World Journal of Gastroenterology|May 12, 2020
Macrophages in metabolic associated fatty liver diseaseJawaher Alharthi, Olivier Latchoumanin, Jacob George, et al.
Trends in Genetics : TIG|May 13, 2020
The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver DiseaseAli Bayoumi, Henning Grønbæk, Jacob George, et al.
Hormones (Athens, Greece)|August 3, 2022
Detangling the interrelations between MAFLD, insulin resistance, and key hormonesShreya C Pal, Mohammed Eslam, Nahum Mendez-Sanchez
Pageof 23